Search Results

Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics

Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024.

continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic

Despite its therapeutic potential, CB2 pharmacology remains difficult to interrogate with confidence.

development GPCR Events, Meetings, and Webinars March 13 - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox

GPCRs in Neuroscience CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

crystal structures of both CBRs.[4–8] A key challenge in CBR modulator development is separating the therapeutic New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.

have been approved as drugs, however they often have serious side effects and too low or temporary therapeutic Pharmacology & Therapeutics   2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007

Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8

February 20, 2024 | Career Opportunities in Pharmacology and Drug Discovery March 13 - 15 | 9th German Pharm-Tox

Conference and Exhibition February 11 - 14, 2024 | 2024 BPS Annual Meeting NEW March 13 - 15 | 9th German Pharm-Tox

This scavenging function should be considered when evaluating the safety and therapeutic efficacy of

within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic

binding and receptor activation will pave the way for significant advancements in the development of therapeutics